Brandzon Co.

Innocan Pharma Corporation (OTCQB: INNPF) (CSE:INNO) (FSE:IP4) released its audited financial results for the year ended December 31,2022, revealing revenue of $2.6 million, an increase of 1205% from approximately $196,000 in 2021. Financial Highlights for the year ended December 31, 2022 Q4...